Cadex Genomics, Corp. – Trademark Portfolio
Entity Type: 03
Cadex Genomics, Corp. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ALIBREX and CADEX GENOMICS. The owner is based in Redwood City, CA.
541 Jefferson Avenue, Suite 100
Redwood City, CA 94063
Showing of trademarks Trademarks
Trademark Classifications
Cadex Genomics, Corp.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Cadex Genomics, Corp. have?
Cadex Genomics, Corp. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Cadex Genomics, Corp. file in?
Cadex Genomics, Corp. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Cadex Genomics, Corp.'s most well-known trademarks?
Cadex Genomics, Corp.'s registered trademark portfolio includes well-known marks such as ALIBREX and CADEX GENOMICS. These are among 2 currently registered trademarks in the portfolio.
What is Cadex Genomics, Corp.'s trademark registration success rate?
Cadex Genomics, Corp. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.